Table 1 Clinicopathologic and cytogenetic features of the successful study cases
Patient | Age/gender | Primary site | Cytologic diagnosis | Cytogenetic abnormality |
|---|---|---|---|---|
1 | 5/M | R. femur | Ewing's sarcoma | t(11;22)(q24;q12) |
2 | 26/M | L. Buttock | Ewing's sarcoma | t(11;22)(q24;q12) |
3 | 6/F | R. Thigh | Ewing's sarcoma | t(11;22)(q24;q12) |
4 | 15/F | R. Buttock | Synovial sarcoma | t(X;18)(p11;q11) |
5 | 35/M | R. Thigh | Synovial sarcoma | t(X;18)(p11;q11) |
6 | 36/M | R. Ankle | Synovial sarcoma | t(X;18)(p11;q11) |
7 | 18/M | R. Buttock | Synovial sarcoma | t(X;18)(p11;q11) |
8 | 31/M | L. Thigh | Synovial sarcoma | t(X;18)(p11;q11) |
9 | 20/M | L. Foot | Synovial sarcoma | t(X;18)(p11;q11) |
10 | 14/M | R. Neck | Alveolar RMS | t(2;13)(q35;q14)a |
